Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Most Radiologists Want to Adopt AI Tools into Clinical Practice, Finds Study

By HospiMedica International staff writers
Posted on 17 Aug 2022

Artificial intelligence (AI) may improve cancer detection and risk prediction during mammography screening, but radiologists’ preferences regarding its characteristics and implementation are unknown. More...

Now, a new study into radiologists’ preferences pertaining to the use of AI as a support tool for cancer detection and risk prediction during mammography screening has found that up to 60% of radiologists intend to adopt AI tools into clinical practice in the near future.

Through qualitative interviews with radiologists, investigators at the University of Washington (Seattle, WA, USA) and Seattle Cancer Care Alliance (Seattle, WA, USA) identified five primary attributes for AI-based breast cancer detection and four for breast cancer risk prediction. The team developed a discrete choice experiment (DCE) based on these attributes and invited 150 U.S.-based radiologists to participate. Each respondent made eight choices for each tool between three alternatives: two hypothetical AI-based tools versus screening without AI. The investigators analyzed sample-wide preferences using random parameters logit models and identified subgroups with latent class models. The respondents (N=66; 44% response rate) were from six diverse practice settings across eight states.

The investigators found that the radiologists were more interested in AI for cancer detection when sensitivity and specificity were balanced (94% sensitivity with <25% of examinations marked) and AI mark-up appeared at the end of the hanging protocol after radiologists complete their independent review. For AI-based risk prediction, the radiologists preferred AI models using both mammography images and clinical data. Overall, 46-60% intended to adopt any of the AI tools presented in the study; 26-33% approached AI enthusiastically but were deterred if the features did not align with their preferences. Based on these findings, the investigators concluded that although most radiologists want to use AI-based decision support, short-term uptake may be maximized by implementing tools that meet the preferences of dissuadable users.

Related Links:
University of Washington 
Seattle Cancer Care Alliance 


Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Ultrasound System
FUTUS LE
Radiology System
Riviera SPV AT
X-Ray System
Leonardo DR mini III
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.